Company Profiles

driven by the PitchBook Platform

AccuTheranostics

AccuTheranostics
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of biomedical and clinical services. The company focuses on the business of individualizing chemotherapy thereby dramatically improving outcomes for cancer patients.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
875 Ellicott Street
Suite 5086
Buffalo, NY 14203
United States

+1 (716) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AccuTheranostics’s full profile, request a free trial.

AccuTheranostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 24-Oct-2012 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AccuTheranostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UB Incubator Accelerator/Incubator 000 0000 000000 0

AccuTheranostics Executive Team (3)

Name Title Board
Seat
Contact
Info
Steven Cerne Co-Founder & Chief Executive Officer
Sherry Bradford Ph.D Co-Founder, President & Chief Scientific Officer
Arvind Thakur Ph.D Co-Founder & Vice President, Scientific Affairs, Research & Development
Questions or concerns about this profile? Reach out to website-support@pitchbook.com